Clinical trial
Efficacy of a Peri-Operative Surgical-Site, Multimodal Drug Injection in Pediatric Patients With Cerebral Palsy Undergoing Hip Surgery: A Randomized Controlled Trial
NCT04074265 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of a Peri-Operative Surgical-Site, Multimodal Drug Injection in Pediatric Patients With Cerebral Palsy Undergoing Hip Surgery: A Randomized Controlled Trial
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 1, 2019
- Completion date
- April 30, 2023
- Enrollment
- 34 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cerebral palsy, hip dysplasia, pain, postoperative